Search by Drug Name or NDC

    NDC 76204-0700-55 Levalbuterol 0.31 mg/3mL Details

    Levalbuterol 0.31 mg/3mL

    Levalbuterol is a RESPIRATORY (INHALATION) SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ritedose Pharmaceuticals, LLC. The primary component is LEVALBUTEROL HYDROCHLORIDE.

    Product Information

    NDC 76204-0700
    Product ID 76204-700_0cf37834-6265-6135-e063-6294a90a2bfd
    Associated GPIs 44201045102510
    GCN Sequence Number 049871
    GCN Sequence Number Description levalbuterol HCl VIAL-NEB 0.31MG/3ML INHALATION
    HIC3 B6W
    HIC3 Description BETA-ADRENERGIC AGENTS, INHALED, SHORT ACTING
    GCN 15665
    HICL Sequence Number 019858
    HICL Sequence Number Description LEVALBUTEROL HCL
    Brand/Generic Generic
    Proprietary Name Levalbuterol
    Proprietary Name Suffix n/a
    Non-Proprietary Name Levalbuterol Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SOLUTION
    Route RESPIRATORY (INHALATION)
    Active Ingredient Strength 0.31
    Active Ingredient Units mg/3mL
    Substance Name LEVALBUTEROL HYDROCHLORIDE
    Labeler Name Ritedose Pharmaceuticals, LLC
    Pharmaceutical Class Adrenergic beta2-Agonists [MoA], beta2-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203653
    Listing Certified Through 2024-12-31

    Package

    NDC 76204-0700-55 (76204070055)

    NDC Package Code 76204-700-55
    Billing NDC 76204070055
    Package 5 POUCH in 1 CARTON (76204-700-55) / 5 AMPULE in 1 POUCH (76204-700-05) / 3 mL in 1 AMPULE
    Marketing Start Date 2017-02-17
    NDC Exclude Flag N
    Pricing Information N/A